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Abstract Using a combination of immunoprecipitation and 
Western blotting with Faza 567 hepatoma cell extracts revealed 
that the large subunit of replication factor C (Alp145; mRFC140) 
was in a complex with proliferating cell nuclear antigen (PCNA). 
Western blotting showed that Alp145 was more abundant in 
nuclear extracts from butyrate-treated hepatoma cells which 
blocks the cells in the Cl phase of the cell cycle than from 
routinely cultured cells. Indirect immunoperoxidase analysis of 
Cl blocked Faza hepatoma cells localized Alp145 protein pre- 
dominantly in the nucleoli. When hepatoma cells were stimulated 
to progress toward the S phase, Alp145 protein was then ob- 
served in both the cytoplasm and the nucleoplasm of these cells. 
Studies with early cultured normal hepatocytes which are pro- 
gressing from Go towards G,, also showed a nucleolus distribution 
for Alp145. This is the first demonstration in mammalian cells 
that the large subunit of replication factor C is associated with 
PCNA in the nucleus and that its distribution within cells changes 
during the cell cycle. 
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1. Introduction 
DNA replication involves a complex multi-enzyme system 
whose activity is tightly regulated during the cell cycle [l]. 
Factors responsible for both the initiation and elongation of 
DNA have been extensively described [2,3]. In the first steps of 
DNA replication, specific proteins are involved in origin recog- 
nition and unwinding of the DNA. Additional proteins such as 
replication factor A (RF-A) are needed to stabilize this complex 
[4]. The initiation of DNA synthesis requires the interaction of 
DNA polymerase c1 with the RF-A complex. Additional repli- 
cation proteins such as Activator 1 (Al) proteins, also known 
as replication fFactor C (RF-C) and the proliferating cell nu- 
clear antigen (PCNA) are required for the fidelity and proces- 
sivity of the polymerases [S-9]. 
Activator 1 (Al) consists of five different subunits of 145,40, 
38, 37 and 36.5 kDa [6]. Al binds to the primer-template 
junction through the 145 kDa subunit although the 37 kDa 
subunit has weak DNA binding, and ATP is bound by the 40 
kDa subunit [5]. Recently, cDNAs for all subunits of human 
Al have been cloned and sequenced and it has been shown that 
each subunit has significant homology with each other and to 
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a lesser extent with two subunits of E. coli DNA polymerase 
III [lo-141. The large subunit of activator 1, Alp145, also 
shows a domain with homology to DNA ligases [15,16]. Al- 
though Alp145 is required for successful DNA replication, 
little is known about its expression during the cell cycle. In 
Saccharomyces cerevisiae it has been shown that the levels of 
two RF-C gene products (RFC2 and RFC3) do not signifi- 
cantly fluctuate during the mitotic cell cycle [17,18]. Here, we 
have studied the expression of the mammalian Alp145 subunit 
of RF-C in rat Faza 567 hepatoma cells and cultured normal 
hepatocytes as a function of the cell cycle. Both hepatoma cells 
and hepatocytes are useful model systems to study the early 
steps of the cell cycle. Hepatoma cells can be synchronized and 
stimulated to growth and normal adult hepatocytes spontane- 
ously progress from G, to the G, phase of the cell cycle, even 
in the absence of DNA synthesis, when prepared by enzymatic 
disruption of the liver [19,20]. After a Gl phase time-lapse of 
48 h, successful DNA synthesis is achieved only when cells are 
stimulated with a mixture of insulin, EGF and pyruvate ([20]; 
Loyer et al., submitted). In this report, we show that Alp145 
is recruited in the nucleus within the G,,!G, transition and/or 
early G, phase in both Faza 567 hepatoma cells and cultured 
normal hepatocytes. Furthermore, immunoprecipitation exper- 
iments demonstrate that Alp145 is in a complex with PCNA. 
2. Materials and methods 
2.1. Reagents 
Anti-Alp145 antibodies were directed against a recombinant protein 
produced from a restriction fragment of the Alp145 (MSW) cDNA 
(amino acid residues 203-545) which was subcloned in a PQE-9 bacte- 
rial expression vector. Affinity-purified fusion protein was used as 
antigen to immunize a rabbit and antiserum was obtained after four 
injections (151. 
2.2. Cells 
Hepatocytes were isolated from male Sprague-Dawley rats using the 
two-step collagenase perfusion method [21]. Cells were collected in L-l 5 
Leibovitz medium and then washed in 0.1 M HEPES buffer, pH 7.6. 
Viability of cells was estimated by the Trypan blue exclusion test. 
Hepatocytes were plated on plastic dishes in a mixture of 75% minimum 
essential medium and 25% medium-199 containing 10% fetal calf serum 
(FCS) and 0.02% bovine serum albumin. 
The Faza 567 cell line has been subcloned from the rat hepatoma cell 
line H4IIEC3 isolated from the Reuber H35 hepatoma [22,23]. 
Hepatoma cells were routinely cultured in Williams’ medium contain- 
ing 10% FCS. To obtain a synchronous population of cells, Faza 567 
cells were arrested in G, phase by addition of 10 mM butyrate for 24 
h. Then, quiescent cultures were stimulated with 10% FCS. DNA syn- 
thesis was monitored by incubation of cells for 4 h with 1 mCi/ml 
[3H]thymidine (5 CYmmol; Amersham, UK). 
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2.3. Immunoprecipitation and Western blotting 
Nuclear proteins were prepared from Faza 567 hepatoma cells as 
described by Dignam et al. [24]. Monoclonal anti-PCNA antibodies 
(Oncogene Science Inc.) were added for 4 h prior addition of protein 
A-Sepharose for 12 h at 4°C. After extensive washes, beads were mixed 
with sample buffer containing 10% SDS and 5% mercaptoethanol. 
Controls were obtained using nuclear extracts incubated with non- 
immune serum. Then, cell lysates, nuclear extracts and proteins im- 
munoprecipitated with anti-PCNA antibodies were loaded into a 6% 
SDS-polyacrylamide gel. Subsequently, proteins were transferred onto 
nitrocellulose membranes. The filters were incubated 2 h at room tem- 
perature with 50 mM Tris-HCl, pH 7.5, containing 0.15 M NaCl, 0.2% 
NP-40 and 3% non-fat dry-milk. Affinity purified anti-Alp145 recom- 
binant protein antibodies were then added in fresh medium containing 
3% non-fat dry-milk. After 2 h, the filters were extensively washed prior 
incubation with horseradish peroxidase-conjugated goat anti-rabbit an- 
tibodies for a further 2 h. Subsequently, nitrocellulose sheets were 
washed extensively before incubation in 4-chloro-1-naphtol/H,02 for 20 
min. 
2.4. Immunocytochemistry 
Alp145 protein was localized in situ using the indirect immunoperox- 
idase method following paraformaldehyde fixation and treatment with 
saponin [25]. Briefly, cell cultures were washed with cold PBS and fixed 
with a 4% paraformaldehyde solution buffered with 0.1 M sodium 
cacodylate, pH 7.4, for 45 min at 4°C. Then, cells were incubated with 
0.2% saponin in PBS for 1 h and subsequently incubated with an 
appropriate dilution of affinity purified anti-Alp145 recombinant pro- 
tein antibodies in PBS containing 0.2% saponin. The second incubation 
was performed with peroxidase-labeled anti-immunoglobulins (Institut 
Pasteur, Paris) diluted in PBS containing 0.2% saponin. Peroxidase 
activity was revealed by incubating cells in a 3.3’-diaminobenzidine/ 
H,Oz solution for 20 min. 
3. Results 
3.1. Acquisition of synchronized Faza hepatoma cells 
Synchronized Faza 567 hepatoma cells were obtained by 
incubating cells with butyrate, thereby resulting in arrest of cells 
in early G, phase of the cell cycle [26]. Then, cells were stimu- 
lated towards the S phase of the cell cycle by addition of fresh 
medium containing 10% FCS. Cells were analyzed at various 
times for [3H]thymidine incorporation (Fig. 1). Addition of 
butyrate resulted in minimal incorporation of [3H]thymidine. 
Twelve hours after stimulation with FCS, [3H]thymidine incor- 
poration started and increased during the following 12 h, then 
decreased for 8 h. 
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Fig. 1. [‘H]Thymidine incorporation in Faza 567 hepatoma cells. Cells 
were first incubated with 10 mM butyrate for 24 h. Then early G, 
arrested cells were stimulated with 10% FCS (time 0). [3H]Thymidine 
incorporation was determined in synchronized cells every 4 h for 32 h 
in triplicate. Data were obtained in cpm/mg of protein and expressed 
as arbitrary unit. 
Fig. 2. Western blots of Alp145 Lanes 1 and 2: nuclear extracts from 
Faza 567 hepatoma cells either routinely cultured (lane 1) of treated 
with 10 mM butyrate for 24 h (lane 2) were resolved on a 6% SDS- 
polyacrylamide gel (50 pg each) and transferred onto a nitrocellulose 
filter which was subsequently incubated with anti-Alp145 antibodies. 
Lane 3: nuclear extracts from routinely cultured Faza hepatoma cells 
were first immunoprecipitated with monoclonal anti-PCNA antibodies. 
Then, protein A-Sepharose was added for 12 h and beads were mixed 
with sample buffer before loading into a 6% SDS-polyacrylamide gel. 
Then, proteins were transferred onto a nitrocellulose membrane which 
was incubated with anti-Alp145 antibodies. Lane 4: cell lysate from 
routinely cultured Faza hepatoma cells was resolved by gel electropho- 
resis prior Western blotting with anti-Alp145 antibodies. Migration 
positions of standard molecular weights (kDa) and Alp145 (arrow- 
head) are indicated. 
3.2. Expression of Alpl45protein in Faza 567 hepatoma cell line 
The expression of Alp145 protein was evaluated in Faza 567 
hepatoma cells by Western blotting (Fig. 2). In nuclear extracts 
from both routinely cultured (lane 1) and butyrate-treated Faza 
hepatoma cells (lane 2), a major band of M, = 145,000 was 
strongly labeled when nitrocellulose filters were incubated with 
specific affinity purified anti-Alp145 antibodies. Staining was 
more intense in nuclear extracts from butyrate-treated cells 
than from control Faza hepatoma cells (lane 2 vs. lane 1). To 
determine whether PCNA and Alp145 were in protein com- 
plex, nuclear extracts prepared from routinely cultured Faza 
567 hepatoma cells were first subjected to immunoprecipitation 
with monoclonal anti-PCNA antibodies prior gel electrophore- 
sis and transfer to nitrocellulose filters that were subsequently 
incubated with anti-Alp145 antibodies. In these conditions, the 
M, = 145,000 polypeptide was strongly labeled and resolved as 
a doublet (lane 3). In cell lysates from routinely cultured Faza 
hepatoma cells the M, = 145,000 polypeptide was also detected 
with additional faster migrating bands which probably corre- 
spond to degradation products (lane 4). 
3.3. Immunolocalization of Alp145 protein in Faza 567 
hepatoma cells 
Alp145 was immunolocalized in Faza hepatoma cells using 
the indirect immunoperoxidase (Fig. 3). In control hepatoma 
cells, Alp145 was detected in both the cytoplasm and the nu- 
cleus of cells (Fig. 3A). In some cells, only the cytoplasm was 
labeled for Alp145. After addition of butyrate for 24 h, the 
nucleus of all hepatoma cells was strongly positive, particularly 
at the level of the nucleolus (Fig. 3B). When cells were stimu- 
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Fig. 3. Immunolocalization of Alp145 in Faza 567 hepatoma cells. Cells were first arrested in G, phase of the cell cycle by addition of 10 mM butyrate 
and stimulated with 10% FCS. Alp145 was visualized by indirect immunoperoxidase in routinely cultured Faza 567 cells (A), after incubation of 
butyrate for 24 h (B) and 24 h (C) and 32 h (D) after stimulation of synchronized cells with 10% FCS. Alp145 was detected in both the cytoplasm 
and the nucleus of cells (arrows). After addition of butyrate for 24 h, the nucleoli of hepatoma cells were strongly positive. x480. 
lated to grow, Alp145 remained associated with the nucleolus 
as shown 24 h after addition of FCS, i.e. at maximum of 
[3H]thymidine incorporation (Fig. 3C). After 32 h of stimula- 
tion, Alp145 was detected predominantly in the cytoplasm of 
Faza 567 hepatoma cells (Fig. 3D). 
3.4. Immunolocalization of Alp145 protein in normal 
hepatocytes 
A 1 p 145 was localized by indirect immunoperoxidase in hepa- 
tocytes prepared from normal adult rats and plated in culture. 
Twenty minutes after cell seeding, Alp145 was localized only 
in the cytoplasm of all hepatocytes (Fig. 4A). After 6 h, both 
the cytoplasm and the nucleus of hepatocytes were labeled, the 
nucleoli of several cells being strongly positive (Fig. 4B). After 
24 h and thereafter, the pattern of Alp145 distribution was 
similar to that in 6 h hepatocyte cultures: Alp145 was detected 
in both the cytoplasm and nucleus of hepatocytes, with several 
nucleoli being strongly labeled (Fig. 4C). In controls, hepato- 
cytes were totally negative when non-immune serum was used 
in the first step of indirect immunoperoxidase (Fig. 4D). 
4. Discussion 
In this report we show that Alp145 is abundant in the cyto- 
plasm of Faza hepatoma cells and is associated with PCNA in 
nuclear extracts. This is the first demonstration in mammalian 
cells that the large subunit of Al is readily associated with 
PCNA in the nucleus, thus indicating that Al is a part of 
chromosomal replicase that includes DNA polymerase 6 and 
PCNA. Similarly, in E. coli, the DNA polymerase II core is 
recruited after the accessory y complex has assembled the 
p dimer of the clamp protein [27,28], whereas in the phage T4, 
the chromosomal replicase is formed by the assembly of the 
polymerase gp43, the accessory gp44gp62 complex and the 
processivity factor gp45 [29]. Immunoprecipitation study with 
anti-PCNA antibodies followed by Western blotting with anti- 
Alp145 antibodies revealed that the M, = 145,000 band was 
resolved as a doublet. Whether this particular feature corre- 
sponds to differences in processing, glycosylation or phospho- 
rylation of Alp145 protein remains to be determined. Both 
immunocytochemistry and Western blotting in Faza 567 
hepatoma cells showed that the distribution of Alp145 protein 
varies depending on the phases of the cell cycle. In routinely 
cultured Faza hepatoma cells, Alp145 staining was diffuse and 
present in both the cytoplasm and the nucleus. Surprisingly, 
after addition of butyrate intense staining was localized in the 
nucleus of all the cells, particularly at the level of nucleoli. 
Accordingly, Western blotting indicated that Alp145 was more 
abundant in nuclear extracts from butyrate-treated cells than 
from control Faza hepatoma cells. Since butyrate is known to 
block cells in early Gl phase of the cell cycle [26], this observa- 
tion indicates that change in Alp145 distribution parallels that 
F Levavasseur et al. IFEBS Letters 363 (1995) 132-136 135 
Fig. 4. Immunolocalization of Alp145 in cultured rat hepatocytes. Alp145 was visualized by indirect immunoperoxidase at 20 min (A), 6 h (B) and 
24 h (C) after cell seeding. Alp145 was detected in the cytoplasm 20 min after cell seeding and in several nucleoli of hepatocytes after 6 h (arrows). 
(D) Staining with non-immune serum in a 24 h hepatocyte culture. x480. 
of PCNA during the cell cycle. Indeed, it has been shown that 
PCNA is preferentially located in the nucleoli of cells in late G, 
phase [30] or in the S phase of the cell cycle [31]. When 
hepatoma cells were stimulated to grow, Alp145 remained as- 
sociated with the nuclei during the S phase of the cell cycle, 
whereas Alp145 was detected predominantly in the cytoplasm 
during the cell cycle progression towards G, and M phases. A 
similar pattern of distribution of PCNA has been previously 
demonstrated by immunofluorescence in both 3T3 cells and 
transformed human amnion cells [30,31]. It is unknown 
whether these changes in the distribution of both PCNA and 
Alp145 are related to a shuttle of these proteins between cyto- 
plasm and nucleus or conformational changes leading to de- 
masking of antigenic determinant. Nevertheless, our immuno- 
peroxidase study indicates that Alp145 activity is associated 
with early events in DNA replication. This hypothesis was 
confirmed in hepatocyte primary cultures. Indeed, dramatic 
change in the distribution of Alp145 was found very early after 
liver disruption by collagenase perfusion and plating of hepato- 
cytes in culture. Thus, immediately after liver perfusion, 
Alp145 was localized exclusively in the cytoplasm of hepato- 
cytes, whereas as early as 6 h after cell seeding the nucleoli of 
numerous hepatocytes were strongly positive. Previous studies 
have shown that during this period of time a transient increase 
of c-fos and c-&n was observed following disruption of rat livers 
indicating an early transition from G, to G, phase of the cell 
cycle in isolated normal hepatocytes [ 19,201. Thus, recruitement 
of Alp145 in the nucleoli of hepatocytes is associated with early 
progression of these cells in the cell cycle in vitro. Studies in 
regenerative liver following partial hepatectomy are required to 
confirm that changes in Alp145 distribution also occurs in 
physiological conditions [32]. 
In conclusion, the present study on Alp145 expression in 
both hepatoma cells and normal hepatocytes in vitro leads to 
the hypothesis that changes in the distribution of Al occurs in 
the cell cycle and confirms that this protein is in complex with 
PCNA in the nucleus. 
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